PortfoliosLab logoPortfoliosLab logo
Trulieve Cannabis Corp (TCNNF)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
CA89788C1041
CUSIP
89788C104

Highlights

Market Cap
$1.16B
Enterprise Value
$1.60B
EPS (TTM)
-$0.61
Total Revenue (TTM)
$1.19B
Gross Profit (TTM)
$683.99M
EBITDA (TTM)
$319.15M
Year Range
$3.02 - $11.83
Target Price
$47.21
ROA (TTM)
-4.25%
ROE (TTM)
-10.07%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Trulieve Cannabis Corp

Often compared with TCNNF:
TCNNF vs. DB.VTCNNF vs. MSOS

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Trulieve Cannabis Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Trulieve Cannabis Corp (TCNNF) has returned -30.49% so far this year and 87.00% over the past 12 months.


Trulieve Cannabis Corp

1D
3.32%
1M
-8.62%
YTD
-30.49%
6M
-29.04%
1Y
87.00%
3Y*
4.19%
5Y*
-33.15%
10Y*

Benchmark (S&P 500 Index)

1D
0.11%
1M
-2.33%
YTD
-3.84%
6M
-1.98%
1Y
29.73%
3Y*
16.86%
5Y*
10.37%
10Y*
12.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Sep 27, 2018, TCNNF's average daily return is +0.10%, while the average monthly return is +1.96%. At this rate, your investment would double in approximately 3.0 years.

Historically, 42% of months were positive and 58% were negative. The best month was Aug 2025 with a return of +102.3%, while the worst month was Nov 2024 at -47.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, TCNNF closed higher 46% of trading days. The best single day was Dec 12, 2025 with a return of +66.6%, while the worst single day was Nov 6, 2024 at -38.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-20.48%-7.53%-12.36%7.86%-30.49%
2025-7.59%-11.27%-9.18%27.98%-19.03%-5.00%14.47%102.30%-8.41%-10.05%-25.66%61.22%67.65%
202479.46%3.53%28.10%15.89%-31.94%-5.42%9.19%-13.86%40.23%-5.74%-47.56%-14.05%-0.51%
2023-10.96%-4.60%-13.06%-3.22%-21.07%-8.20%8.42%33.88%7.03%-26.11%23.29%-6.09%-31.18%
2022-24.26%8.93%-1.91%-31.52%2.58%-22.16%11.29%11.67%-40.58%37.06%10.64%-41.27%-70.90%
202126.38%15.12%-1.09%-8.59%-8.73%-1.21%-12.80%-17.40%-0.37%-6.47%6.08%-2.58%-17.74%

Benchmark Metrics

Trulieve Cannabis Corp has an annualized alpha of 14.66%, beta of 0.82, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since September 28, 2018.

  • This stock participated in 138.23% of S&P 500 Index downside but only 71.15% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
14.66%
Beta
0.82
0.04
Upside Capture
71.15%
Downside Capture
138.23%

Return for Risk

Risk / Return Rank

TCNNF ranks 64 for risk / return — better than 64% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


TCNNF Risk / Return Rank: 6464
Overall Rank
TCNNF Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
TCNNF Sortino Ratio Rank: 7474
Sortino Ratio Rank
TCNNF Omega Ratio Rank: 6868
Omega Ratio Rank
TCNNF Calmar Ratio Rank: 6262
Calmar Ratio Rank
TCNNF Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Trulieve Cannabis Corp (TCNNF) and compare them to a chosen benchmark (S&P 500 Index).


TCNNFBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.53

0.88

-0.35

Sortino ratio

Return per unit of downside risk

1.84

1.37

+0.48

Omega ratio

Gain probability vs. loss probability

1.21

1.21

0.00

Calmar ratio

Return relative to maximum drawdown

1.09

1.39

-0.30

Martin ratio

Return relative to average drawdown

2.29

6.43

-4.14

Explore TCNNF risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Trulieve Cannabis Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Trulieve Cannabis Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Trulieve Cannabis Corp was 93.88%, occurring on Apr 4, 2025. The portfolio has not yet recovered.

The current Trulieve Cannabis Corp drawdown is 88.56%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.88%Mar 17, 20211019Apr 4, 2025
-65.26%Oct 3, 2018366Mar 18, 202096Aug 4, 2020462
-32.07%Aug 17, 202028Sep 24, 202031Nov 6, 202059
-13.53%Feb 11, 202117Mar 8, 20215Mar 15, 202122
-12.78%Jan 14, 20219Jan 27, 20217Feb 5, 202116

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Trulieve Cannabis Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Trulieve Cannabis Corp is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TCNNF relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TCNNF has a P/S ratio of 1.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for TCNNF in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TCNNF has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with TCNNF

Add Trulieve Cannabis Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with TCNNF